NCT00502658

Brief Summary

Excessive body weight is becoming a concern around the world, for example over half of the American adult population is overweight or obese. The purpose of this study is to determine whether dietary supplements and shakes containing a combination of nutrients/ingredients individually shown in research studies to reduce hunger, enhance metabolism, reduce the body's ability to 'store' fat, and enhance energy, promote healthy body weight and composition over 12 weeks. A further study objective is to determine whether the inclusion of a personal, easy to use, energy tracking device for the measurement of daily energy intake and expenditure also helps with the promotion of healthy body weight and body composition. In this prospective, blinded study 120 volunteers who meet the entrance criteria including a BMI 25-35 kg/m2 and sign the informed consent form to participate in a 12 week long study will be recruited. All subjects will consume a multi-vitamin, mineral and fish oil supplement. Subjects will be randomly assigned to a control or experimental group and stratified by BMI 25-30 and \>30-35 kg/m2, age, and gender with an equal number of subjects in each strata across groups. A subset of subjects will also wear a personal energy tracking device. Subjects will be instructed how to incorporate the shakes and supplements into their current diet and encouraged to incorporate fruits, vegetables, whole grains, and other healthy foods into their current meals and to exercise at least 30 minutes five days per week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2007

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

July 12, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 17, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

March 28, 2008

Status Verified

March 1, 2008

Enrollment Period

5 months

First QC Date

July 12, 2007

Last Update Submit

March 26, 2008

Conditions

Keywords

OverweightObeseDietary SupplementsShakesNutritionOverweight and Obese Adults (BMI 25-35)

Outcome Measures

Primary Outcomes (1)

  • Body weight changes

    Several measurements over 12 weeks

Secondary Outcomes (1)

  • Biophotonic scanner score, blood chemistry and metabolic profiles, adverse events, subjects' supplement preference, quality of life measurements

    Several measurements over 12 weeks

Interventions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18-65 years of age.
  • Body Mass Index (BMI) between 25-35
  • Willing to stop taking any nutritional supplements

You may not qualify if:

  • Currently taking weight loss medication or supplements
  • Currently smoke
  • Taking any prescription medications
  • Experienced at least a 10 pound weight loss over the past 2 months.
  • History of serious heart problems (i.e. heart attack, angina, bypass surgery).
  • Diagnosed with diabetes (insulin or non-insulin dependent)
  • Known history of gastrointestinal diseases (i.e. Crohn's disease, chronic diarrhea, Inflammatory Bowel Disease)
  • Undergone surgical procedure for weight loss (i.e. gastroplasty, gastric by-pass, gastrectomy, stomach stapling, gastric banding, etc).
  • History of stroke or seizure activity
  • Medical conditions known to affect serum lipids
  • History of uncontrolled hypertension or with a current measured blood pressure with diastolic above 90 or systolic above 140 mm Hg
  • A total serum cholesterol above 240 mg/dL
  • Known HIV infection
  • Known history of depression and currently taking anti-depression medications
  • Treated for cancer in the last 5 years
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pharmanex

Provo, Utah, 84601, United States

Location

MeSH Terms

Conditions

OverweightObesityTremor

Interventions

MineralsNutrients

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDyskinesiasNeurologic ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Inorganic ChemicalsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Doug Burke, PhD

    Pharmanex

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

July 12, 2007

First Posted

July 17, 2007

Study Start

July 1, 2007

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

March 28, 2008

Record last verified: 2008-03

Locations